Japanese Nobel Prize winner Shinya Yamanaka says he sees potential for tapping artificial intelligence to more quickly and accurately check the safety of induced pluripotent stem (iPS) cells in regenerative medicine.
“I want to use artificial intelligence to analyze the enormous amount of data on the human genome and assess the safety (of the cells) in an objective manner and without oversight,” Yamanaka said in a recent interview.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
PHOTO GALLERY (CLICK TO ENLARGE)
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.